RBC Capital的分析师已将HOOKIPA Pharma的股票评级从"优于大市"下调至"与大市同步",并大幅下调目标价,从48.00美元降至2.00美元。此次降级是在HOOKIPA宣布重组计划之后做出的,该计划包括裁减80%的员工,并暂停其主要项目的临床开发。RBC ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
RBC Capital analyst Brian Abrahams maintained a Hold rating on Hookipa Pharma (HOOK – Research Report) on February 28 and set a price target of ...
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on ...
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing cancer immunotherapies that harness arenaviruses to induce robust and durable antigen-specific CD8 + T cells to kill ...
HOOKIPA Pharma Inc. announced that it will not proceed with a planned all-share acquisition of Poolbeg Pharma plc, as discussed in previous communications. This decision follows non-binding ...
HOOKIPA Pharma (HOOK) announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 participants enrolled across five sites in the United ...
The wintertime waves at Ho'okipa Beach are so white and frothy that hardcore surfers and windsurfers can't stay away (waves can reach as high as 30 feet). The water is definitely too rough for ...
In a challenging year for biotech firms, Hookipa Pharma Inc (NASDAQ:HOOK). shares have tumbled to a 52-week low, touching down at $1.71. According to InvestingPro analysis, the company ...
The boards of directors of Hookipa Pharma (HOOK) and Poolbeg Pharma announced that they have entered into non-binding discussions for an all-share acquisition by Hookipa of Poolbeg to create a ...
After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma. Jan. 2, Hookipa inked a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果